Insider trading

Period: 120 months Stock: MC Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

62 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

62 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

62 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

62 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
62 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
62 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

62 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
19 Feb 2025
Cantor Eric Vice Chairman, MD
Sold at will
$1.22M 16,530 at 74.00
7.0%
Not planned
30 Jul 2024
MOELIS KENNETH Chairman, CEO · indirect
Sold at will
$6.44M 93,506 at 68.87
93.5%
Sold half or more
13 May 2024
MAHMOODZADEGAN NAVID Co-President, MD
Sold at will
$2.47M 44,980 at 54.92
100%
Sold half or more
10 May 2024
MOELIS KENNETH Chairman, CEO
Sold at will
$2.01M 37,102 at 54.11
87.4%
Sold half or more
9 May 2024
MOELIS KENNETH Chairman, CEO
Sold at will
$2.16M 40,000 at 53.98
48.5%
Not planned
1 Mar 2024
MAHMOODZADEGAN NAVID Co-President, MD
Sold at will
$1.05M 19,483 at 53.88
30.2%
Not planned
29 Feb 2024
MOELIS KENNETH Chairman, CEO
Sold at will
$4.06M 75,000 at 54.11
46.5%
Not planned
29 Feb 2024
MAHMOODZADEGAN NAVID Co-President, MD
Sold at will
$2.75M 50,772 at 54.11
44.1%
Not planned
29 Feb 2024
RAICH JEFFREY Co-President, MD
Sold at will
$2.42M 44,710 at 54.23
100%
Sold half or more
23 Feb 2024
RAICH JEFFREY Co-President, MD
Sold at will
$2.46M 45,093 at 54.62
50.2%
Sold half or more
21 Feb 2024
MOELIS KENNETH Chairman, CEO
Sold at will
$6.75M 128,277 at 52.60
44.2%
Not planned
21 Feb 2024
MAHMOODZADEGAN NAVID Co-President, MD
Sold at will 2×
$5.63M 106,211 at 53.00
75.8%
Sold half or more
21 Feb 2024
RAICH JEFFREY Co-President, MD
Sold at will
$2.09M 39,781 at 52.60
30.7%
Not planned
20 Feb 2024
MAHMOODZADEGAN NAVID Co-President, MD
Sold at will
$1.42M 25,642 at 55.29
32.1%
Not planned
16 Feb 2024
MAHMOODZADEGAN NAVID Co-President, MD
Sold at will
$1.12M 20,001 at 55.82
20.0%
Not planned
10 Nov 2023
MOELIS KENNETH Chairman, CEO
Sold at will
$2.08M 50,000 at 41.57
66.7%
Sold half or more
3 Mar 2023
MAHMOODZADEGAN NAVID Co-President, MD
Sold, plan not stated
$1.00M 23,323 at 43.05
18.9%
1 Mar 2023
MAHMOODZADEGAN NAVID Co-President, MD
Sold, plan not stated
$2.33M 54,009 at 43.13
30.5%
28 Feb 2023
MAHMOODZADEGAN NAVID Co-President, MD
Sold, plan not stated
$2.26M 52,209 at 43.22
22.8%
22 Feb 2023
MAHMOODZADEGAN NAVID Co-President, MD
Sold, plan not stated
$2.88M 68,561 at 42.06
23.0%
22 Feb 2023
MOELIS KENNETH Chairman, CEO
Sold, plan not stated
$1.91M 45,507 at 42.06
31.6%
22 Feb 2023
RAICH JEFFREY Co-President, MD
Sold, plan not stated
$1.54M 36,592 at 42.06
45.0%
10 Feb 2023
RAICH JEFFREY Co-President, MD
Sold, plan not stated 2×
$1.70M 38,074 at 44.58
68.9%
Sold half or more
9 Feb 2023
RAICH JEFFREY Co-President, MD
Sold, plan not stated
$1.93M 42,637 at 45.30
43.6%
31 Jan 2023
MOELIS KENNETH Chairman, CEO · indirect
Sold, plan not stated
$2.06M 44,676 at 46.12
100%
Sold half or more
30 Jan 2023
MOELIS KENNETH Chairman, CEO · indirect
Sold, plan not stated
$2.77M 60,093 at 46.12
57.4%
Sold half or more
27 Jan 2023
MOELIS KENNETH Chairman, CEO · indirect
Sold, plan not stated
$3.42M 73,976 at 46.18
41.4%
15 Nov 2022
MOELIS KENNETH Chairman, CEO · indirect
Sold, plan not stated
$4.67M 100,000 at 46.74
32.9%
14 Nov 2022
MOELIS KENNETH Chairman, CEO
Sold, plan not stated 2×
$3.82M 82,921 at 46.01
62.5%
Sold half or more
22 Feb 2022
MAHMOODZADEGAN NAVID Co-President, MD
Sold, plan not stated
$2.52M 53,518 at 47.12
26.9%
22 Feb 2022
MOELIS KENNETH Chairman, CEO
Sold, plan not stated
$1.62M 34,370 at 47.12
20.6%
22 Feb 2022
RAICH JEFFREY Co-President, MD
Sold, plan not stated
$1.59M 33,762 at 47.12
25.6%
27 Apr 2021
MOELIS KENNETH Chairman, CEO · indirect
Sold, plan not stated
$1.63M 28,559 at 57.06
8.3%
23 Apr 2021
MOELIS KENNETH Chairman, CEO · indirect
Sold, plan not stated
$1.04M 18,184 at 57.11
5.0%
6 Apr 2021
MOELIS KENNETH Chairman, CEO · indirect
Sold, plan not stated
$1.88M 32,760 at 57.50
8.3%
5 Apr 2021
MOELIS KENNETH Chairman, CEO · indirect
Sold, plan not stated
$3.39M 60,000 at 56.56
13.2%
19 Mar 2021
MOELIS KENNETH Chairman, CEO · indirect
Sold, plan not stated
$3.40M 60,000 at 56.64
10.7%
18 Mar 2021
MOELIS KENNETH Chairman, CEO · indirect
Sold, plan not stated
$3.49M 60,000 at 58.13
9.7%
17 Mar 2021
MOELIS KENNETH Chairman, CEO · indirect
Sold, plan not stated
$3.44M 60,000 at 57.28
8.8%
16 Mar 2021
MOELIS KENNETH Chairman, CEO · indirect
Sold, plan not stated
$3.38M 60,000 at 56.28
8.1%
15 Mar 2021
MOELIS KENNETH Chairman, CEO · indirect
Sold, plan not stated
$3.35M 60,000 at 55.75
7.5%
1 Mar 2021
MOELIS KENNETH Chairman, CEO
Sold, plan not stated
$2.38M 43,613 at 54.50
33.1%
19 Feb 2021
MOELIS KENNETH Chairman, CEO
Sold, plan not stated
$1.55M 28,234 at 54.78
86.2%
Sold half or more
18 Feb 2021
MOELIS KENNETH Chairman, CEO
Sold, plan not stated 2×
$3.94M 72,064 at 54.64
68.8%
Sold half or more
16 Feb 2021
MOELIS KENNETH Chairman, CEO
Sold, plan not stated 2×
$3.40M 61,987 at 54.89
37.2%
27 Oct 2020
MAHMOODZADEGAN NAVID Co-President, MD · indirect
Sold, plan not stated 2×
$46.10M 1,195,848 at 38.55
100%
Sold half or more
27 Oct 2020
RAICH JEFFREY Co-President, MD · indirect
Sold, plan not stated 2×
$24.41M 633,100 at 38.55
100%
Sold half or more
27 May 2020
MAHMOODZADEGAN NAVID Co-President, MD
Sold, plan not stated
$2.43M 72,632 at 33.47
100%
Sold half or more
20 Feb 2020
MOELIS KENNETH Chairman, CEO
Sold, plan not stated
$2.91M 79,331 at 36.72
32.6%
20 Feb 2020
MAHMOODZADEGAN NAVID Co-President, MD
Sold, plan not stated
$2.73M 74,269 at 36.72
50.6%
Sold half or more
Showing 1–50 of 62. Page 1 of 2 Older →